SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063380
Filing Date
2023-11-14
Accepted
2023-11-14 08:30:28
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tern-20230930.htm   iXBRL 10-Q 2386213
2 EX-10.1 tern-ex10_1.htm EX-10.1 82733
3 EX-10.2 tern-ex10_2.htm EX-10.2 8145
4 EX-10.3 tern-ex10_3.htm EX-10.3 32540
5 EX-31.1 tern-ex31_1.htm EX-31.1 18657
6 EX-31.2 tern-ex31_2.htm EX-31.2 18651
7 EX-32.1 tern-ex32_1.htm EX-32.1 10479
8 EX-32.2 tern-ex32_2.htm EX-32.2 10473
  Complete submission text file 0000950170-23-063380.txt   9721752

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20230930_lab.xml EX-101.LAB 547566
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20230930.xsd EX-101.SCH 67964
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tern-20230930_cal.xml EX-101.CAL 46409
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20230930_pre.xml EX-101.PRE 404175
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tern-20230930_def.xml EX-101.DEF 251098
52 EXTRACTED XBRL INSTANCE DOCUMENT tern-20230930_htm.xml XML 1950661
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 231401758
SIC: 2834 Pharmaceutical Preparations